Concepedia

R.A. Giacobbe

RG

Statistics

Publications

37

Citations

3K

H-Index

32

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (Spain)

AstraZeneca (United States)

Merck Biopharma Co., Ltd. (Japan)

Merck Canada Inc. (Canada)

R.A. Giacobbe is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, microbiology, and drug discovery.

Publications per year

1989–2020

37

Publications

37

Discovery of Novel Antifungal (1,3)-β- <scp>d</scp> -Glucan Synthase Inhibitors

Janet C. Onishi, M. Meinz, John R. Thompson et al. · Antimicrobial Agents and Chemotherapy · 2000 · 319 citations · Full text

, , +17

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 271 citations

, , +16

Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii

William F. Penwell, Adam B. Shapiro, R.A. Giacobbe et al. · Antimicrobial Agents and Chemotherapy · 2015 · 247 citations · Full text

, , +17

The Discovery of Australifungin, a Novel Inhibitor of Sphinganine N-Acyltransferase from Sporormiella australis. Producing Organism, Fermentation, Isolation, and Biological Activity.

Suzanne Mandala, Rosemary Thornton, BETH R. FROMMER et al. · The Journal of Antibiotics · 1995 · 189 citations · Full text

, , +16

Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against <i>Candida</i> and <i>Aspergillus</i> Species

Frank C. Odds, Mary Motyl, Roberto Andrade et al. · Journal of Clinical Microbiology · 2004 · 173 citations · Full text

, , +16

1–5 of 37